Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Cell And Gene Therapy Manufacturing Services Global Market Opportunities And Strategies To 2033

Cell And Gene Therapy Manufacturing Services Market 2024 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases, Metabolic Diseases, Other Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2033

Cell And Gene Therapy Manufacturing Services Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 $3500.00 | Pages : 278 | Published : May 2024 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell And Gene Therapy Manufacturing Services Market Definition

Cell and gene therapy manufacturing services represent a pioneering sector within the biopharmaceutical industry, dedicated to the production of innovative treatments that modify the genetic material of individuals or use living cells to treat or prevent disease.

Cell therapy involves the transfer of cells with the relevant function into a patient, often aiming to restore or establish normal cell function, replacing damaged or absent cells. Gene therapy, on the other hand, involves altering the genetic material within a patient's cells to treat or prevent disease, offering potential cures for a wide range of genetic and acquired diseases.

The cell and gene therapy manufacturing services market consists of sales, by entities (organizations, sole traders or partnerships), of cell and gene therapy manufacturing services that involve the production of therapeutic products in the form of cells or genetic material for the treatment of various diseases. Cell and gene therapy manufacturing services aid in the advancement and production of remedies for degenerative illnesses, tissue injuries and genetic abnormalities.

Book your 30 minutes free consultation with our research experts

Contact Us

Cell And Gene Therapy Manufacturing Services Market Size

The global cell and gene therapy manufacturing services market reached a value of nearly $6,962.62 million in 2023, having grown at a compound annual growth rate (CAGR) of 12.52% since 2018. The market is expected to grow from $6,962.62 million in 2023 to $15,074.20 million in 2028 at a rate of 16.71%. The market is then expected to grow at a CAGR of 17.70% from 2028 and reach $34,051.20 million in 2033.

Growth in the historic period resulted from rising autoimmune diseases, rising prevalence of genetic disorders and rising demand for personalized medicine. Factors that negatively affected growth in the historic period were low healthcare access and high costs associated with the treatment.

Going forward, the growing number of cancer cases, growing healthcare expenditure, rising investments in research and development and increasing aging population will drive the growth. Factor that could hinder the growth of the cell and gene therapy manufacturing services market in the future include shortage of skilled workers.

Cell And Gene Therapy Manufacturing Services Market Drivers

The key drivers of the cell and gene therapy manufacturing services market include:

Growing Healthcare Expenditure

The growing healthcare expenditure is expected to drive the cell and gene therapy manufacturing services market. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services and goods within a specific period, encompassing expenses related to medical treatment, hospitalization, pharmaceuticals and other healthcare-related activities. The growing healthcare expenditure is driven by factors such as technological advancements, an aging population and increasing demand for healthcare services. The healthcare expenditure is used for advanced cell and gene therapy manufacturing services, reflecting a growing emphasis on cutting-edge medical solutions and personalized treatments. For instance, in June 2023, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, between 2022 and 2031, health spending in the USA is expected to grow at an average rate of 5.4%, surpassing the average GDP growth rate of 4.6%. This will lead to an increase in the share of health spending in the Gross Domestic Product (GDP) from 18.3% in 2021 to 19.6% in 2031. Therefore, the growing healthcare expenditure will drive the cell and gene therapy manufacturing services market.

Cell And Gene Therapy Manufacturing Services Market Restraints

The key restraints on the cell and gene therapy manufacturing services market include:

Shortage Of Skilled Workers

A shortage of skilled workers is expected to hamper the growth of the cell and gene therapy manufacturing services market going forward. The shortage of skilled workers for cell and gene therapy manufacturing services is a critical insufficiency of qualified personnel possessing the specialized knowledge and expertise required in the intricate processes involved in producing these advanced therapeutic products. This scarcity limits the efficient scaling and operation of manufacturing facilities dedicated to cell and gene therapy, impacting the industry's ability to meet the growing demand for these innovative medical treatments. For instance, in April 2022, according to the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, there's expected to be a shortage of 17,800 to 48,000 primary care physicians by 2034. Therefore, the lack of skilled workers will negatively impact the growth of the cell and gene therapy manufacturing services market.

Cell And Gene Therapy Manufacturing Services Market Trends

Major trends shaping the cell and gene therapy manufacturing services market include:

Strategic Investments To Expand Manufacturing Capacities

Companies in the cell and gene therapy manufacturing services market are focusing on investing in the in-house manufacturing capacity to meet growing demand and scale up production. This increases flexibility, scalability, dedicated supply channels, decreased internal infrastructure requirements, ownership of supply channels, greater agility in process troubleshooting and enhanced process optimization. For instance, in December 2023, Fujifilm Corporation, a Japan-based healthcare company, made a significant investment of $200 million to expand its cell therapy manufacturing capacity through two subsidiaries, Fujifilm Cellular Dynamics and Fujifilm Diosynth Biotechnologies. This investment is aimed at strengthening Fujifilm's manufacturing capacity to support iPSC-derived cell therapies and other advanced therapies. These expansions will include new development labs, manufacturing clean rooms and increased production capacity to meet the growing demand in the cell therapy market, which is predicted to grow by more than 30% annually.

Strategic Collaborations For Advancing Cancer Treatment Production Processes

Companies in the cell and gene therapy manufacturing services market are focusing on strategic collaborations to advance the development of production processes for cancer treatments and gain a competitive edge in the market. Strategic collaborations for advancing the development of production processes for cancer treatments, specifically cell therapy, involve interdisciplinary partnerships between research institutions, pharmaceutical companies and manufacturing entities. For instance, in April 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, collaborated with Arsenal Biosciences, Inc., a US-based clinical-stage, programmable cell therapy company to expand the advancement of manufacturing processes for new cancer treatments. It creates a production method for their programable autologous T cells used to treat cancer. Thermo Fisher offers solutions and expertise to support ArsenalBio's research and development, to provide more treatment options for patients with challenging cancers.

Opportunities And Recommendations In The Cell And Gene Therapy Manufacturing Services Market

Opportunities – The top opportunities in the cell and gene therapy manufacturing services market segmented by type will arise in the gene therapy segment, which will gain $5,400.18 million of global annual sales by 2028. The top opportunities in the cell and gene therapy manufacturing services market segmented by indication will arise in the oncology diseases segment, which will gain $2,857.96 million of global annual sales by 2028. The top opportunities in the cell and gene therapy manufacturing services market segmented by application will arise in the clinical manufacturing segment, which will gain $4,972.85 million of global annual sales by 2028. The top opportunities in the cell and gene therapy manufacturing services market segmented by end-user will arise in the pharmaceutical and biotechnology segment, which will gain $5,386.33 million of global annual sales by 2028. The cell and gene therapy manufacturing services market size will gain the most in the USA at $3,538.21 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends cell and gene therapy manufacturing companies to focus on advancing "off-the-shelf" allogeneic cell therapy, focus on implementing advanced technologies like the navigation platform, focus on integrated packaging solutions for cell and gene therapy, focus on gene therapy segment, expand in emerging markets, continue to focus on developed markets, focus on expanding in-house manufacturing capacity, focus on strategic collaborations for cancer treatment advancement, focus on competitive pricing strategies, participate in trade shows and events, continue to use B2B promotions, prioritize educational content and thought leadership , leverage digital marketing channels effectively and focus on other end-users segment for growth.

Cell And Gene Therapy Manufacturing Services Market Segmentation

The cell and gene therapy manufacturing services market is segmented by type, by indication, by application and by end-user.

By Type –
The cell and gene therapy manufacturing services market is segmented by type into:
    • a) Gene Therapy
    • b) Cell Therapy
The gene therapy market was the largest segment of the cell and gene therapy manufacturing services market segmented by type, accounting for 61.8% or $4,303.02 million of the total in 2023. Going forward, the gene therapy segment is expected to be the fastest growing segment in the cell and gene therapy manufacturing services market segmented by type, at a CAGR of 17.66% during 2023-2028.

By Indication –
The cell and gene therapy manufacturing services market is segmented by indication into:
    • a) Central Nervous System Disorders
    • b) Ophthalmology Diseases
    • c) cardiovascular diseases
    • d) Infectious Diseases
    • e) Orthopedic Diseases
    • f) Oncology Diseases
    • g) Metabolic Diseases
    • h) Other Diseases
The oncology diseases market was the largest segment of the cell and gene therapy manufacturing services market segmented by indication, accounting for 27.0% or $1,879.91 million of the total in 2023. Going forward, the oncology diseases segment is expected to be the fastest growing segment in the cell and gene therapy manufacturing services market segmented by indication, at a CAGR of 20.31% during 2023-2028.

By Application –
The cell and gene therapy manufacturing services market is segmented by application into:
    • a) Commercial Manufacturing
    • b) Clinical Manufacturing
The clinical manufacturing market was the largest segment of the cell and gene therapy manufacturing services market segmented by application, accounting for 66.4% or $4,625.48 million of the total in 2023. Going forward, the commercial manufacturing segment is expected to be the fastest growing segment in the cell and gene therapy manufacturing services market segmented by application, at a CAGR of 18.56% during 2023-2028.

By End-User –
The cell and gene therapy manufacturing services market is segmented by end-user into:
    • a) Academic and Research Institutes
    • b) Pharmaceutical and Biotechnology Companies
    • b) Other End-Users
The pharmaceutical and biotechnology market was the largest segment of the cell and gene therapy manufacturing services market segmented by end-user, accounting for 64.7% or $4,502.15 million of the total in 2023. Going forward, the other end-users’ segment is expected to be the fastest growing segment in cell and gene therapy manufacturing services market segmented by end-user, at a CAGR of 17.98% during 2023-2028.

By Geography - The cell and gene therapy manufacturing services market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the cell and gene therapy manufacturing services market, accounting for 46.9% or $3,266.22 million of the total in 2023. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the cell and gene therapy manufacturing services market will be Asia-Pacific and North America where growth will be at CAGRs of 18.11% and 17.37% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 15.48% and 12.18% respectively.

Cell And Gene Therapy Manufacturing Services Market Competitive Landscape

Major Competitors are:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Charles River Laboratories International Inc.
  • Catalent Inc

    • Other Competitors Include:

  • Lonza Group Ltd.
  • Boehringer Ingelheim
  • Fujifilm Holdings Corporation
  • Samsung Biologics
  • Novartis International AG
  • Sibiono GeneTech Co. Ltd.
  • Zhejiang Teruisi Biopharmaceuticals Co., Ltd.
  • Shanghai Sunway Biotech Co., Ltd.
  • 3D Medicines Inc.
  • GenScript Biotech Corporation
  • WuXi AppTec
  • Samsung Biologics
  • Fujifilm Diosynth Biotechnologies
  • Hitachi Chemical Advanced Therapeutics Solutions
  • Celltrion Healthcare Co., Ltd
  • Albumedix Ltd
  • Kite Pharma
  • Gilead Sciences
  • Oxford BioTherapeutics
  • Freeline Therapeutics
  • Avectas
  • Lonza
  • Novartis AG
  • DiNAQOR AG
  • Pfizer
  • Vivet Therapeutics
  • Allergan
  • Takeda Pharmaceutical
  • PsiOxus Therapeutics
  • PPG Industries Inc.
  • Versatile
  • The Sherwin-Williams Company
  • RPM International
  • DSM
  • Bluebird bio-Inc.
  • CRISPR Therapeutics AG
  • Vertex Pharmaceuticals Incorporated
  • Beam Therapeutics Inc.
  • BlueRock Therapeutics
  • ExCellThera.
  • Plast Labor
  • Pluristem Therapeutics Inc.
  • Kadimastem
  • Bonus Biogroup Ltd.
  • ALJ Health
  • Gilead Sciences, Inc.
  • Merck
  • Biogen SA
  • Sanofi
  • Bayer East Africa Ltd.
  • Adcock Ingram

      • Table Of Contents

      1Executive Summary

      1.1 Cell And Gene Therapy Manufacturing Services – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Cell And Gene Therapy Manufacturing Services Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Gene Therapy

      6.4.2 Cell Therapy

      6.5 Market Segmentation By Indication

      6.5.1 Central Nervous System Disorders

      6.5.2 Ophthalmology Diseases

      6.5.3 Cardiovascular Diseases

      6.5.4 Infectious Diseases

      6.5.5 Orthopedic Diseases

      6.5.6 Oncology Diseases

      6.5.7 Metabolic Diseases

      6.5.8 Other Diseases

      6.6 Market Segmentation By Application

      6.6.1 Commercial Manufacturing

      6.6.2 Clinical Manufacturing

      6.7 Market Segmentation By End-User

      6.7.1 Academic And Research Institutes

      6.7.2 Pharmaceutical And Biotechnology Companies

      6.7.3 Other End-Users

      7 Cell And Gene Therapy Manufacturing Services Market - Macro Economic Scenario

      7.1 COVID-19 Impact On The Cell And Gene Therapy Manufacturing Services Market

      7.2 Impact Of The War In Ukraine On The Cell And Gene Therapy Manufacturing Services Market

      7.3 Impact Of High Inflation On The Cell And Gene Therapy Manufacturing Services Market

      8 Major Market Trends

      8.1 Strategic Investments To Expand Manufacturing Capacities

      8.2 Strategic Collaborations For Advancing Cancer Treatment Production Processes

      8.3 Development Of Next-Generation CAR T Therapies

      8.4 Enhancement In Cell And Gene Therapy Manufacturing With Innovative Technologies

      8.5 Innovative Solutions Driving Efficiency In Cell And Gene Therapy Manufacturing

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Cell And Gene Therapy Manufacturing Services Market Segmentation

      10.1 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.4 Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Cell And Gene Therapy Manufacturing Services Market, Regional and Country Analysis

      11.1 Global Cell And Gene Therapy Manufacturing Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Cell And Gene Therapy Manufacturing Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.2 65

      12.1.3 65

      12.1.4 65

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific Cell And Gene Therapy Manufacturing Services Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 77

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis

      13.6 UK Market

      13.7 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Cell And Gene Therapy Manufacturing Services Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Cell And Gene Therapy Manufacturing Services Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Cell And Gene Therapy Manufacturing Services Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.3 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Thermo Fisher Scientific Inc.

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial performance

      19.3 Merck KGaA

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 F. Hoffman-La Roche Ltd.

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Charles River Laboratories International Inc.

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial overview

      19.6 Catalent Inc

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      20 Competitive Benchmarking

      21 Competitive Dashboard

      22 Key Mergers And Acquisitions

      22.1 QHP Capital Acquired Applied StemCell Inc.

      22.2 Fujifilm Corporation Acquired Atara Biotherapeutics Inc.

      22.3 Thermo Fisher Scientific Inc. Acquired PeproTech, Inc.

      22.4 Charles River Laboratories International, Inc. Acquired Vigene Biosciences, Inc.

      22.5 Thermo Fisher Scientific Inc. Acquired Henogen SA

      23 Future Outlook and Potential Analysis

      23.1 Global Cell And Gene Therapy Manufacturing Services Market In 2028 – Countries Offering Most New Opportunities

      23.2 Global Cell And Gene Therapy Manufacturing Services Market In 2028 – Segments Offering Most New Opportunities

      23.3 Global Cell And Gene Therapy Manufacturing Services Market In 2028 – Growth Strategies

      23.3.1 Market Trend Based Strategies

      23.3.2 Competitor Strategies

      24 Appendix

      24.1 Geographies Covered

      24.2 Market Data Sources

      24.3 Research Methodology

      24.4 Currencies

      24.5 The Business Research Company

      24.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Cell And Gene Therapy Manufacturing Services Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Cell And Gene Therapy Manufacturing Services Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Cell And Gene Therapy Manufacturing Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Global Cell And Gene Therapy Manufacturing Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 9: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 10:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 11: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 14: China GDP Per Capita, 2018-2023, $
    • Table 15:  China Population, 2018-2028, Millions
    • Table 16: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 34: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 35:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 36: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 54: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 55:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 56: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 62: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 63:  North America Population, By Country, 2018-2028, Millions
    • Table 64: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 67: USA GDP Per Capita, 2018-2023, $
    • Table 68:  USA Population, 2018-2028, Millions
    • Table 69: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 75: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 76:  South America Population, By Country, 2018-2028, Millions
    • Table 77: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 83: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 84:  Middle East Population, By Country, 2018-2028, Millions
    • Table 85: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 88: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 89:  Africa Population, By Country, 2018-2028, Millions
    • Table 90: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 93: Global Cell And Gene Therapy Manufacturing Services Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 94: Thermo Fisher Scientific Inc – Financial Overview, 2018 – 2022, $ Billion
    • Table 95: Merck KGaA – Financial Overview, 2018– 2022, $ Billion
    • Table 96: F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
    • Table 97: Charles River Laboratories International – Financial Overview, 2018 – 2022, $ Billion
    • Table 98: Catalent Inc – Financial Overview, 2018 – 2022, $ Billion
    • Table 99: Cell And Gene Therapy Manufacturing Services Market, Competitive Benchmarking (In USD Millions)
    • Table 100: Cell And Gene Therapy Manufacturing Services Market, Competitive Dashboard
    • Table 101: Global Cell And Gene Therapy Manufacturing Services Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 102: Global Cell And Gene Therapy Manufacturing Services Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028
    • Table 103: Global Cell And Gene Therapy Manufacturing Services Market Size Gain ($ Million), Segmentation By Indication, 2023 – 2028
    • Table 104: Global Cell And Gene Therapy Manufacturing Services Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028
    • Table 105: Global Cell And Gene Therapy Manufacturing Services Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028
    • Table 106: Cell And Gene Therapy Manufacturing Services Market Data Sources

    List Of Figures

      Figure 1: Global Cell And Gene Therapy Manufacturing Services Market Segmentation By Type
    • Figure 2: Global Cell And Gene Therapy Manufacturing Services Market Segmentation By Indication
    • Figure 3: Global Cell And Gene Therapy Manufacturing Services Market Segmentation By Application
    • Figure 4: Global Cell And Gene Therapy Manufacturing Services Market Segmentation By End-User
    • Figure 5: Global Cell And Gene Therapy Manufacturing Services Market, Historic, 2018 – 2023, $ Million
    • Figure 6: Global Cell And Gene Therapy Manufacturing Services Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 7: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Global Cell And Gene Therapy Manufacturing Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Global Cell And Gene Therapy Manufacturing Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: Asia-Pacific Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: China Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: India Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Japan Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Australia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: Indonesia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: South Korea Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: Western Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: UK Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: Germany Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: France Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Italy Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Spain Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Eastern Europe Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: Russia Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: North America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: USA Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: Canada Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: South America Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Brazil Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Middle East Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 78: Africa Cell And Gene Therapy Manufacturing Services Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 79: Global Cell And Gene Therapy Manufacturing Services, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 80: Thermo Fisher Scientific Inc – Financial Overview, 2018 – 2022, $ Billion
    • Figure 81: Merck KGaA – Financial Overview, 2018 – 2022, $ Billion
    • Figure 82: F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
    • Figure 83: Charles River Laboratories International – Financial Overview, 2018 – 2022, $ Billion
    • Figure 84: Catalent Inc – Financial Overview, 2018 – 2022, $ Billion
    • Figure 85: Geographic Regions Covered

    Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

    Read More

    Global Central Lab Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Biohacking Market Overview In 2022?

    Read More

    How Will The Healthcare Claims Management Solutions Market Grow In 2022?

    Read More

    The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

    Read More

    Revenue Cycle Management Software Global Market Report 2024 – By Product (Integrated, Standalone), By Function (Claim And Denial, Medical Biling And Coding, Patient Insurance Eligibility Check, Payment Remittance, Electronic Health Record (EHR), Clinical Documentation Improvement (CDI), Other Functions), By Deployment (Web based, On premise, Cloud based) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Payer Services Global Market Report 2024 –By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (Revenue Cycle Management, Healthcare Reimbursement, Medical Billing Outsourcing, Other Applications), By End-User (Public Payers, Private Payers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Prenatal Testing & Newborn Screening Global Market Report 2024 – By Diagnostic Type (Non-Invasive, Invasive), By Technology (Screening Technology, Diagnostic Technology), By End user (Hospitals, Diagnostic centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Medical Billing Outsourcing Global Market Report 2024 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

    View Report

    Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

    View Report

    Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

    View Report

    Value Based Care Payment Global Market Report 2024 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer) – Market Size, Trends, And Global Forecast 2024-2033

    View Report